[1]牟秦娇 张玥 王楠.无导线起搏器在特殊人群中植入的研究进展[J].心血管病学进展,2023,(8):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]
　MOU QinjiaoZHANG YueWANG Nan.Analysis of Implantation of Leadless Pacemakers in Special Populations[J].Advances in Cardiovascular Diseases,2023,(8):694.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.006]
点击复制

无导线起搏器在特殊人群中植入的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2023年8期
页码:
694
栏目:
综述
出版日期:
2023-08-25

文章信息/Info

Title:
Analysis of Implantation of Leadless Pacemakers in Special Populations
作者:
牟秦娇 1 张玥2 王楠3
(1.宁夏医科大学临床医学院,宁夏 银川 750000;2.苏州大学苏州医学院,江苏 苏州 215123;3.甘肃省人民医院心内科干部病区,甘肃 兰州 730000)
Author(s):
MOU Qinjiao1ZHANG Yue2WANG Nan3
?1.School of Clinical Medicine,Ningxia Medical University,Yinchuan,750000,Ningxia,China2.Suzhou Medical College,Soochow University,Soochow,215123,Jiangsu,China3.Cardiology Cadre Ward,Gansu Provincial Hospital,Lanzhou,730000,Gansu,China)
关键词:
心血管病学; 无导线起搏器; 特殊人群
Keywords:
Cardiology; Leadless pacemaker; Special population
DOI:
10.16806/j.cnki.issn.1004-3934.2023.08.006
摘要:
无导线起搏器（LP）被开发并引入临床，以解决传统经静脉起搏器导线与囊袋相关的并发症。在对既往LP可用临床数据的回顾中，笔者发现其植入并不复杂，但因特殊人群自身情况的复杂性，LP的植入存在一定难度。现就近几年LP相关文献进行回顾，并分析LP在特殊人群中植入的可操作性、成功性、安全性以及有效性，为特殊人群植入LP的临床治疗和研究提供指引，具有重要的临床价值。
Abstract:
Leadless pacemakers(LP) were developed and introduced into the clinic to address the complications related to the lead and pocket of traditional transvenous pacemaker. In a review of previous clinical data available on LP,the author found that their implantation was not complicated,but that implantation of LP is difficult due to the complexity of the special population’s own condition. This paper reviews the LP-related literature in recent years and analyses the operability ,success,safety and efficacy of LP implantation in special populations,providing guidance for clinical treatment and research on LP implantation in special populations,which is of great clinical value

参考文献/References:

[1] Tjong FV,Reddy VY. Permanent leadless cardiac pacemaker therapy:a comprehensive review[J]. Circulation,2017,135(15):1458-1470.

[2] Darlington D,Brown P,Carvalho V,et al. Efficacy and safety of leadless pacemaker:a systematic review,pooled analysis and meta-analysis[J]. Indian Pacing Electrophysiol J,2022,22(2):77-86.

[3] Wilson DG,Morgan JM,Roberts PR. "Leadless" pacing of the left ventricle in adult congenital heart disease[J]. Int J Cardiol,2016,209:96-97.

[4] 陈诚,张疆华,邢强,等. 单中心60例无导线心脏起搏器植入临床经验分析[J]. 中华心律失常学杂志,2021,25(1):37.

[5] Ahmad J,Bawa D,Sethi S,et al. Successful leadless pacemaker implantation in a patient with dextroposition of the heart[J]. Heart Rhythm Case Rep,2021,7(5):319-322.

[6] Imamura T,Koi T,Kataoka N,et al. Micra trans-catheter leadless pacemaker implantation in a patient with large right heart[J]. J Cardiol Cases,2021,24(3):136-139.

[7] Huang J,Zhang W,Pan X,et al. Successful application of snare-kissing-catheter technique to implant leadless pacemaker in severely dilated right heart[J]. Pacing Clin Electrophysiol,2021,44(5):960-962.

[8] Alyesh D,Cunnane R. Successful leadless pacemaker deployment in a patient with challenging right heart anatomy using a double snare technique[J]. Heart Rhythm Case Rep,2019,5(8):399-401.

[9] Hiramatsu T,Mizutani Y,Yanagisawa S,et al. Usefulness of the snare technique during leadless pacemaker implantation for a patient with a severely dilated right atrium[J]. Int Heart J,2022,63(1):159-162.

[10] Sanhoury M,Fassini G,Tundo F,et al. Rescue leadless pacemaker implantation in a pacemaker-dependent patient with congenital heart disease and no alternative routes for pacing[J]. J Atr Fibrillation,2017,9(5):1542.

[11] Afzal MR,Ackers J,Hummel JD,et al. Safety of implantation of a leadless pacemaker via femoral approach in the presence of an inferior vena cava filter[J]. Pacing Clin Electrophysiol,2017,40(8):975-976.

[12] 李广平 ,上官文锋. 无导线起搏器研究进展[J]. 医学综述,2019,25(20):3953-3957.

[13] 元小冬. 脑静脉系统血栓形成[J]. 中国综合临床 ,2009,25(4):446-448.

[14] Chen X,Huang W. Strategies to overcome complicated situations in leadless pacemaker implantation[J]. Pacing Clin Electrophysiol,2021,44(12):1959-1962.

[15] Kita K,Le TT,Doshi RN. Implantation of a leadless pacemaker via left subclavian vein following transvenous pacemaker extraction[J]. Heart Rhythm Case Rep,2020,6(6):338-340.

[16] Kotschet E,Alasti M,Alison J. Micra implantation in a patient with transposition of great arteries[J]. Pacing Clin Electrophysiol,2019,42(2):117-119.

[17] Garweg C,Vandenberk B,Foulon S,et al. Leadless pacemaker for patients following cardiac valve intervention[J]. Arch Cardiovasc Dis,2020,113(12):772-779.

[18] McGill M,Roukoz H,Jimenez E,et al. Leadless pacemaker placement in a pediatric tetralogy of fallot patient with previous transcatheter valve replacement[J]. J Electrocardiol,2019,56:52-54.

[19] Morani G,Bolzan B,Pepe A,et al. Leadless pacemaker through tricuspid bioprosthetic valve:early experience[J]. J Arrhythm,2021,37(2):414-417.

[20] Theis C,Huber C,Kaesemann P,et al. Implantation of leadless pacing systems in patients early after tricuspid valve surgery:a feasible option[J]. Pacing Clin ectrophysiol,2020,43(12):1486-1490.

[21] Beurskens NEG,Tjong FVY,de Bruin-Bon RHA,et al. Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up[J]. Circ Arrhythm Electrophysiol,2019,12(5):e007124.

[22] Rordorf R,Savastano S,Bontempi L,et al. Leadless pacing in cardiac transplant recipients:primary results of a multicenter case experience[J]. J Electrocardiol,2020,60:33-35.

[23] Araj FG,Morlend RM,Daniels JD. Leadless pacemaker implant after heart transplant[J]. Am J Cardiol,2019,124(3):455-456.

[24] Araj FG. Conduction abnormalities and tricuspid regurgitation after cardiac transplant:is a leadless pacemaker part of the solution?[J]. ASAIO J,2020,66(3):e56.

[25] Anwar U,Ajijola OA,Shivkumar K,et al. Towards a leadless wirelessly controlled intravenous cardiac pacemaker[J]. IEEE Trans Biomed Eng,2022,69(10):3074-3086.

[26] Chang D,Gabriels JK,Soo Kim B,et al. Concomitant leadless pacemaker implantation and lead extraction during an active infection[J]. J Cardiovasc Electrophysiol,2020,31(4):860-867.

[27] Zhang J,He L,Xing Q,et al. Evaluation of safety and feasibility of leadless pacemaker implantation following the removal of an infected pacemaker[J]. Pacing Clin Electrophysiol,2021,44(10):1711-1716.

[28] Li YD,MaiMaiTi AM,Cao GQ,et al. A prospective comparison of four methods for preventing pacemaker pocket infections[J]. Artif Organs,2021,45(4):411-418.

[29] 王红雨. 70岁以上高龄老人健康体适能评价指标体系的构建与应用研究[J]. 苏州大学,2015.

[30] Pagan E,Gabriels J,Khodak A,et al. Safety of leadless pacemaker implantation in the very elderly[J]. Heart Rhythm,2020,17(12):2023-2028.

[31] 梁静,史冬梅,赵迎新,等. 无导线起搏器临床应用的初步探讨及随访结果分析[J]. 心肺血管病杂志,2020,39(12):1440-1443+1456.

[32] 曾少颖 ,区曦,石继军,等. 儿童安装永久性心脏起搏器方法的临床探讨[J]. 中国小儿急救医学,2006(01):41-43.

[33] Jedrzejczyk-Patej E,Wozniak A,Litwin L,et al. Successful implantation of leadless pacemakers in children:a case series[J]. Eur Heart J Case Rep,2020,4(3):1-6.

[34] Tejman-Yarden S,Nof E,Beinart R,et al. Leadless pacemaker implantation in a pediatric patient with prolonged sinus pauses[J]. Pediatr Cardiol,2018,39(4):844-847.

[35] Gallotti RG,Biniwale R,Shannon K,et al. Leadless pacemaker placement in an 18-kilogram child:procedural approach and technical considerations[J]. Heart Rhythm Case Rep,2019,5(11):555-558.

[36] Hackett G,Aziz F,Samii S,et al. Delivery of a leadless transcatheter pacing system as first-line therapy in a 28-kg pediatric patient through proximal right internal jugular surgical cutdown[J]. J Innov Card Rhythm Manag,2021,12(4):4482-4486.

[37] Breatnach CR,Dunne L,Al-Alawi K,et al. Leadless micra pacemaker use in the pediatric population:device implantation and short-term outcomes[J]. Pediatr cardiol,2020,41(4):683-686.

[38] Mahendran AK,Bussey S,Chang PM. Leadless pacemaker implantation in a four-year-old,16-kg child[J]. J Innov Card Rhythm Manag,2020,11(10):4257-4261.

[39] De Filippo P,Malanchini G,Leidi C,et al. Elective replacement of a 4-year-old leadless pacemaker:new approach for end-of-life management[J]. J Cardiovasc Electrophysiol,2021,32(4):1171-1173.

相似文献/References:

[1]许少华,张曼,综述,等.晚钠电流与舒张性心力衰竭[J].心血管病学进展,2016,(2):213.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.030]
　XU Shaohua,ZHANG Man,ZHANG Jin,et al.Late Sodium Current and Diastolic Heart Failure[J].Advances in Cardiovascular Diseases,2016,(8):213.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.030]
[2]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
　HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(8):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[3]孙静美 尹德春 曲秀芬.炎症信号与心房颤动[J].心血管病学进展,2020,(1):31.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.009]
　SUN Jingmei,YIN Dechun,QU Xiufen.Inflammatory Signals Associated with Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2020,(8):31.[doi:10.16806/j.cnki.issn.1004-3934.2020.01.009]
[4]马娟 范洁.无导线起搏器与传统起搏器并发症比较[J].心血管病学进展,2022,(9):819.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
　MA Juan,FAN Jie.Comparison of Complications Between Leadless Cardiac Pacemaker and Traditional Pacemaker[J].Advances in Cardiovascular Diseases,2022,(8):819.[doi:10.16806/j.cnki.issn.1004-3934.2022.09.013]
[5]王学文?柯元甲?赵庆彦.自主神经调控免疫重构与房颤的发生[J].心血管病学进展,2023,(7):645.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.016]
　WANG Xuewen,KE Yuanjia,ZHAO Qingyan.Autonomic Nerve Regulates Immune Remodeling and The Occurrence of Atrial Fibrillation[J].Advances in Cardiovascular Diseases,2023,(8):645.[doi:10.16806/j.cnki.issn.1004-3934.2023.07.016]

更新日期/Last Update: 2023-09-21